CHECKMATE PHARMACEUTICALS IN's ticker is CMPI and the CUSIP is 162818108. A total of 35 filers reported holding CHECKMATE PHARMACEUTICALS IN in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,775,000 | +6.7% | 556,423 | -4.0% | 0.00% | – |
| Q4 2021 | $1,664,000 | +24.6% | 579,861 | +72.3% | 0.00% | – |
| Q3 2021 | $1,336,000 | -33.4% | 336,587 | 0.0% | 0.00% | – |
| Q2 2021 | $2,005,000 | -56.1% | 336,587 | -10.5% | 0.00% | – |
| Q1 2021 | $4,565,000 | +143.2% | 376,011 | +192.2% | 0.00% | – |
| Q4 2020 | $1,877,000 | +159.3% | 128,687 | +104.5% | 0.00% | – |
| Q3 2020 | $724,000 | – | 62,918 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|